TMCnet News
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Endo International plc Investors and Encourages Investors to Contact the FirmGlancy Prongay & Murray LLP ("GPM") announces that a class action lawsuit has been filed on behalf of investors who purchased Endo International plc ("Endo International" or the "Company") (NASDAQ: ENDP) securities between March 2, 2015 and May 6, 2016, inclusive (the "Class Period"). Endo International investors have until July 25, 2016 to file a lead plaintiff motion. Investors who have suffered losses on their Endo International investments are encouraged to contact Lesley Portnoy of GPM to discuss their legal rights in this class action at 310-201-9150 or by email to [email protected]. The Complaint alleges that throughout the Class Period, Defendants ade materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Endo Pharmaceuticals' arrangements with PBMs with respect to the migraine therapy Frova included questionable incentives intended to increase sales revenues; (ii) consequently, Endo's revenues and revenue projections relied in part on unsustainable arrangements; and (iii) as a result of the foregoing, Defendants' statements about Endo's business, operations, and prospects were false and misleading and/or lacked a reasonable basis. On May 5, 2016, Endo International lowered its 2016 forecasts, citing "previously unanticipated headwinds," including the "loss of exclusivity" for its Voltaren Gel medicine, "increasing competition," and delays on regulatory actions. On this news the Company's shares fell sharply in value, thereby injuring investors. If you purchased shares of Endo International during the Class Period you may move the Court no later than July 25, 2016 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at http://glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. View source version on businesswire.com: http://www.businesswire.com/news/home/20160615006307/en/ |
